Linezolid versus vancomycin for MRSA nosocomial pneumonia

被引：0
|
作者：
不详
机构：
来源：
FUTURE MICROBIOLOGY | 2010年 / 5卷 / 12期
关键词：
D O I：
暂无
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：1763 / 1763
页数：1
相关论文
共 50 条
  • [31] Relationship between the MIC of vancomycin and clinical outcome in patients with MRSA nosocomial pneumonia
    Eun Young Choi
    Jin Won Huh
    Chae-Man Lim
    Younsuck Koh
    Sung-Han Kim
    Sang-Ho Choi
    Yang Soo Kim
    Mi-Na Kim
    Sang-Bum Hong
    Intensive Care Medicine, 2011, 37 : 639 - 647
  • [32] Modeling the economic impact of linezolid versus vancomycin in confirmed nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus
    Dipen A Patel
    Andrew F Shorr
    Jean Chastre
    Michael Niederman
    Andrew Simor
    Jennifer M Stephens
    Claudie Charbonneau
    Xin Gao
    Dilip Nathwani
    Critical Care, 18
  • [33] Cost-effectiveness of linezolid versus vancomycin in suspected methicillin-resistant staphylococcus aureus in nosocomial pneumonia in Germany
    Grünewald, T
    De Cock, E
    Sorensen, SV
    Baker, TM
    Resch, A
    Hardewig, J
    Duttagupta, S
    VALUE IN HEALTH, 2004, 7 (06) : 758 - 758
  • [34] Modeling the economic impact of linezolid versus vancomycin in confirmed nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus
    Patel, Dipen A.
    Shorr, Andrew F.
    Chastre, Jean
    Niederman, Michael
    Simor, Andrew
    Stephens, Jennifer M.
    Charbonneau, Claudie
    Gao, Xin
    Nathwani, Dilip
    CRITICAL CARE, 2014, 18 (04)
  • [35] Effectiveness of linezolid versus vancomycin treatment for MRSA skin and soft tissue infections
    Yim, M.
    Steingisser, J.
    Kan, R.
    Nshala, A.
    Larson, R.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2010, 14 : E394 - E394
  • [36] Linezolid Versus Vancomycin in the Empiric Treatment of Nosocomial Pneumonia: A Cost-Utility Analysis Incorporating Results from the ZEPHyR Trial
    Collins, Curtis D.
    Schwemm, Ann K.
    VALUE IN HEALTH, 2015, 18 (05) : 614 - 621
  • [37] Contribution of linezolid to the treatment of nosocomial pneumonia
    Gouin, F
    PRESSE MEDICALE, 2003, 32 (13): : S13 - S16
  • [38] LINEZOLID VS VANCOMYCIN FOR TREATMENT OF NOSOCOMIAL PNEUMONIA DUE TO METHICILLIN-RESISTANT S AUREUS
    Takada, Hiroaki
    Hifumi, Toru
    Koido, Yuichi
    Kuroda, Yasuhiro
    Kato, Hiroshi
    CRITICAL CARE MEDICINE, 2016, 44 (12)
  • [39] Linezolid and vancomycin for methicillin-resistant Staphylococcus aureus nosocomial pneumonia -: The subtleties of subgroup analyses
    Powers, JH
    Ross, DB
    Lin, D
    Soreth, J
    CHEST, 2004, 126 (01) : 314 - 315
  • [40] Cost-effectiveness of linezolid versus vancomycin in the treatment of nosocomial pneumonia suspected to be caused by methicillin-resistant Staphylococcus aureus in Spain
    Leon, C.
    Gomez, Mateos J. M.
    Catala, R.
    Vazquez, M. J.
    Alvarez, Rocha L.
    Najera, M. D.
    Rubio-Terres, C.
    Garcia, M.
    Escudero, Lopez-Cepero E.
    VALUE IN HEALTH, 2007, 10 (06) : A439 - A440
12345